Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant Temozolomide
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Innovative SonoCloud-9 Device for Blood Brain Barrier Opening in First Line Temozolomide Glioblastoma Patients. (NCT04614493) | Assistance Publique - Hôpitaux de Paris | 2021-09-11 |
Track Eligible for the Standard of Care Including Concurrent Temoradiation and Adjuvant Temozolomide automatically
Every clearance here is in the API, with alerts when new ones post.